Home › NDC Lookup › RxCUI directory › RxCUI 1737244

2 ML clindamycin 150 MG/ML Injection — RxCUI 1737244

Name: 2 ML clindamycin 150 MG/ML Injection (RxCUI 1737244)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1737244 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1737244

Official name2 ML clindamycin 150 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asclindamycin 300 MG per 2 ML Injection; clindamycin 300 MG in 2 ML Injection; clindamycin (as clindamycin phosphate) 300 MG per 2 ML Injection

FDA products mapped12

Package NDCs mapped14

Reported Medicaid activity (SDUD)2,104 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clindamycin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Bacterial vaginosis (BV) is not a sexually transmitted infection in the traditional sense — it's an overgrowth of certain bacteria that naturally live in the vagina, causing an imb...
What is the vaginal cream actually treating — is bacterial vaginosis an STI?
No — and this is really important. The Clindesse vaginal cream contains mineral oil, which can break down latex. That means condoms and diaphragms may not protect you from pregnanc...
Can I use a condom or diaphragm while using the vaginal cream?

📖 Read our full Clindamycin Topical guide →

🕸️ Concept Web — How 2 ML clindamycin 150 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML clindamycin 150 MG/ML Injection RxCUI 1737244 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Clindamycin 2582 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Cleocin 202862 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Clindamycin Injection 1737230 SCDF
- Clindamycin Injectable Product 1152782 SCDG
- Clindamycin Injection [Cleocin] 1737232 SBDF
- Cleocin Injectable Product 1172329 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Clindamycin 150 MG/ML 323888 SCDC
- 2 ML clindamycin 150 MG/ML Injection [Cleocin] 1737245 SBD
- Clindamycin 150 MG/ML [Cleocin] 706460 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Clindamycin 150 MG/ML SCDC · 323888
Clindamycin Injection SCDF · 1737230
Clindamycin Injectable Product SCDG · 1152782

Brand-Name Concepts

2 ML clindamycin 150 MG/ML Injection [Cleocin] SBD · 1737245
Clindamycin 150 MG/ML [Cleocin] SBDC · 706460
Clindamycin Injection [Cleocin] SBDF · 1737232
Cleocin Injectable Product SBDG · 1172329
Cleocin BN · 202862

📦 FDA Products & Package NDCs

12 products · 14 package NDCs

14 package NDCs map to RxCUI 1737244 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00009-0728-09	5 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (0009-0728-09) /...	Cleocin Phosphate	Pharmacia & Upjohn Company LLC	1972-10-02
00009-0775-26	25 VIAL in 1 CARTON (0009-0775-26) / 4 mL in 1 VIAL (0009-0...	Cleocin Phosphate	Pharmacia & Upjohn Company LLC	1972-10-02
00009-0870-26	25 VIAL in 1 CARTON (0009-0870-26) / 2 mL in 1 VIAL (0009-0...	Cleocin Phosphate	Pharmacia & Upjohn Company LLC	1972-10-02
00009-0902-18	25 VIAL in 1 CARTON (0009-0902-18) / 6 mL in 1 VIAL (0009-0...	Cleocin Phosphate	Pharmacia & Upjohn Company LLC	1972-10-02
00009-3051-02	25 VIAL in 1 CARTON (0009-3051-02) / 2 mL in 1 VIAL (0009-3...	Cleocin Phosphate	Pharmacia & Upjohn Company LLC	2019-11-18
00009-4073-04	25 VIAL in 1 CARTON (0009-4073-04) / 4 mL in 1 VIAL (0009-4...	Cleocin Phosphate	Pharmacia & Upjohn Company LLC	2019-11-18
00009-5095-06	25 VIAL in 1 CARTON (0009-5095-06) / 6 mL in 1 VIAL (0009-5...	Cleocin Phosphate	Pharmacia & Upjohn Company LLC	2019-11-18
00404-9837-02	1 VIAL in 1 BAG (0404-9837-02) / 2 mL in 1 VIAL	CLEOCIN PHOSPHATE	Henry Schein, Inc.	2022-01-09
00404-9838-04	1 VIAL in 1 BAG (0404-9838-04) / 4 mL in 1 VIAL	Clindamycin	Henry Schein, Inc.	2022-01-09
25021-0115-02	25 VIAL in 1 CARTON (25021-115-02) / 2 mL in 1 VIAL	Clindamycin	Sagent Pharmaceuticals	2012-05-15
25021-0115-04	25 VIAL in 1 CARTON (25021-115-04) / 4 mL in 1 VIAL	Clindamycin	Sagent Pharmaceuticals	2012-05-15
25021-0115-06	25 VIAL in 1 CARTON (25021-115-06) / 6 mL in 1 VIAL	Clindamycin	Sagent Pharmaceuticals	2012-05-15
71872-7191-01	1 VIAL in 1 BAG (71872-7191-1) / 2 mL in 1 VIAL	Clindamycin	Medical Purchasing Solutions, LLC	2020-01-07
71872-7324-01	1 VIAL in 1 BAG (71872-7324-1) / 2 mL in 1 VIAL	Cleocin Phosphate	Medical Purchasing Solutions, LLC	2024-02-02

Observed labelers: Pharmacia & Upjohn Company LLC (7) · Sagent Pharmaceuticals (3) · Henry Schein, Inc. (2) · Medical Purchasing Solutions, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ml · median

$1.2242

Range $1.2242–$1.2242 · middle 50% $1.2242–$1.2242 · 2 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0736	Inj, clindamycin phosp 300mg	12	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.